Novartis Ag (NVS) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access NVS Annual Balance Sheets →
Looking at balance sheet data from Novartis Ag through Dec 31 2024 provides insight into Dec 31 2025's solvency and capital structure over time.
Quarterly Report, GAAP in USD millions
ITEM
(Dec 31 2025)
0 0 0 (Dec 31 2024)
Assets
Cash And Cash Equivalents11,435.00
Current Tax Assets Current205.00
Cash & Short-term Investments11,640.00
Accounts receivable8,937.00
Notes Receivable, Current6,269.00
Other Current Assets4,608.00
Total Current Assets30,460.00
Equipment/Property/Plant Net10,782.00
Goodwill net25,567.00
Intangible Assets29,411.00
Deferred Tax Assets5,438.00
Other Assets, Noncurrent8,297.00
Total Assets110,949.00
Liabilities
Short-term Debt794.00
Other Liabilities, Current27,278.00
Total Current Liabilities27,278.00
Total Long-term Debt0.00
Deferred Tax Liabilities, Net LI3,397.00
Other liabilities, Noncurrent33,725.00
Total Liabilities64,400.00
Stockholders' Equity
Other Equity18,631.00
Common Stockholder's Equity46,566.00
Total Stockholder's Equity46,549.00
Liabilities & Stockholder's Equity110,949.00
4 historic quarters locked

Sign in to unlock the full Novartis Ag balance sheet history.

About Novartis Ag Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 20-F (Period: 20251231)
  • Filed with the SEC: February 4, 2026
  • Source: nvs-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001114448-26-000004

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.